(lp0
S"Analysts Set Aggressive Price Target for pSivida Corp.  StockNewsUnion - 7 hours ago pSivida Corp.  is a biotechnology firm serving the U.S. and U.K. markets. In today's trading PSDV shares gained 4.65% to close at $1.80.Unusual Volume Spotted in pSivida Corp.  Stock - Melville Review"
p1
aS"pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results GlobeNewswire  - Feb 7, 2017 WATERTOWN, Mass., Feb. 07, 2017  -- pSivida Corp.  , a leader in the development of sustained release drug products and technologies, today reported financial results for its fiscal 2017 second quarter and&nbsp;...pSivida's  CEO Nancy Lurker on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha"
p2
aS'PSivida Redux: Multiple Opportunities For Value Creation Seeking Alpha - Oct 4, 2016 In a prior article I presented the case that the market potential for Medidur in Posterior Uveitis was likely to be small. In addition to Medidur, pSidiva has diversified assets that includes royalty streams on marketed products and platform ...'
p3
aS"pSivida Corp. PSDV  Wall Street Journal - Feb 11, 2011 News pSivida Corp.PSDV. Significant News Only. 03/15/17; Press Release. Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology  Annual Meeting."
p4
aS"Topline Results from First Phase 3 Trial of pSivida's Medidur Presented at ... GlobeNewswire  - Aug 15, 2016 WATERTOWN, Mass., Aug. 15, 2016  -- pSivida Corp.  , a leader in the development of sustained release drug delivery products primarily for eye diseases, announced that Dr."
p5
aS'pSivida Corp. appoints Nancy Lurker chief executive officer Proactive Investors Australia - Sep 16, 2016 pSivida Corp.  has appointed Nancy Lurker as its president and chief executive officer and a member of the board of directors.pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO - GlobeNewswire '
p6
aS'Sell-side Target Update on pSivida Corp.  Aiken Advocate - 17 hours ago Zacks research also gives calculated recommendations from sell-side analysts that cover company shares. These recommendations land on a simplified scale provided by Zacks Research.'
p7
aS'PSivida - A Growth Biotech Company With Approaching Catalysts Seeking Alpha - Dec 4, 2015 PSivida  is a microcap biotechnology company, specialized in the development of sustained release drug delivery products.'
p8
aS"pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference GlobeNewswire  - Sep 22, 2016 WATERTOWN, Mass., Sept. 22, 2016  -- pSivida Corp.  , a leader in the development of sustained release drug delivery products primarily for eye diseases, announced today that Nancy Lurker, the Company's&nbsp;..."
p9
aS"Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for ... GlobeNewswire  - Mar 15, 2017 WATERTOWN, Mass., March 15, 2017  -- pSivida Corp.  , a leader in the development of sustained release drug products and technologies, today announced that an abstract supporting the Company's&nbsp;..."
p10
a.